Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pharmacol Rep ; 67(5): 1010-5, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26398397

RESUMO

BACKGROUND: Kahweol is a diterpene present in the oil derived from coffee beans. Although several pharmacological activities of kahweol are already well described in the literature, no study was done in order to assess the analgesic activity of this substance. Thus, the aim of this study was to investigate the possible peripheral antinociceptive effect of kahweol. Considering that the opioid peptides have been implicated in peripheral antinociception induced by non-opioidergic compounds, the present study also evaluated the endogenous opioids involvement in this effect. METHODS: The rat paw pressure test was used, and hyperalgesia was induced by intraplantar injection of prostaglandin E2 (2µg/paw). All drugs were administered subcutaneously in the hindpaws of male Wistar rats. The expression of ß-endorphin was examined by immunohistochemistry in the skin tissue samples of the plantar surface of rat right hindpaws. RESULTS: Intraplantar injection of kahweol (40 and 80µg) induced significant peripheral antinociception. The antinociceptive effect of kahweol was due to a local peripheral action because the higher dose (80µg/paw) did not produce any effect in the contralateral paw. The opioid receptor antagonist naloxone (50 and 100µg/paw) prevented action of kahweol (80µg/paw) and the aminopeptidases inhibitor bestatin (400µg/paw) potentiated the antinociceptive effect of kahweol (40µg/paw). Furthermore, kahweol treatment increased the intensity of ß-endorphin immunoreactivity in the epithelium of rat paws. CONCLUSIONS: The results discussed here provide evidence that kahweol treatment has peripheral antinociceptive effect and suggest that this effect is mediated by the release of endogenous opioids.


Assuntos
Analgésicos/farmacologia , Café/química , Diterpenos/farmacologia , Peptídeos Opioides/farmacologia , Animais , Dinoprostona , Hiperalgesia/induzido quimicamente , Hiperalgesia/tratamento farmacológico , Leucina/análogos & derivados , Leucina/farmacologia , Masculino , Naloxona/farmacologia , Antagonistas de Entorpecentes/farmacologia , Dor/induzido quimicamente , Dor/tratamento farmacológico , Medição da Dor , Peptídeos/farmacologia , Pressão , Ratos , Ratos Wistar , Pele/efeitos dos fármacos , Pele/metabolismo , beta-Endorfina/biossíntese
2.
Appl Physiol Nutr Metab ; 35(2): 184-7, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20383229

RESUMO

Hypertensive subjects present an increased nociceptive threshold, and the lack or delay of pain perception may impede detection of angina and myocardial infarction. Nutritional interventions, like potassium chloride (KCl) diet supplementation, and exercises are common nonpharmacological indications for treating hypertension. Spontaneous hypertensive rats (SHR) and normotensive male Wistar rats were submitted to a combination of exercise and KCl diet supplementation. Exercise reduced the nociceptive threshold in SHR; however, this effect was inhibited by KCl supplementation. Exercise and KCl supplementation did not alter systolic blood pressure. Reduction of the nociceptive threshold by exercise may be important for the detection of angina and myocardial infarction in hypertensive individuals.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Suplementos Nutricionais , Terapia por Exercício , Hipertensão/terapia , Limiar da Dor/efeitos dos fármacos , Esforço Físico , Cloreto de Potássio/administração & dosagem , Animais , Modelos Animais de Doenças , Hipertensão/fisiopatologia , Masculino , Medição da Dor , Ratos , Ratos Endogâmicos SHR , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA